San Francisco,10
October 2018: The global western
blotting market is
anticipated to reach a value of USD 958.4 millionby 2025, according to a new
report by Grand View Research, Inc. Rising number of cases with HIV are
increasingly contributing towards the growth of western blotting market. This
kind of testing is highly effective in detecting HIV among people. According to
UNAIDS, nearly 36.7 million people were living with HIV throughout the world in
2015. Such high prevalence of HIV is expected to accelerate the demand for
products used in western blotting. Lyme diseases also require western blotting
to detect Borrelia burgdorferi (Bb), which causes
such diseases. Other diseases which require western blot for detection of
specific proteins include mad cow disease, hepatitis, and feline
immunodeficiency.
Moreover, significant investments in
R&D activities made by pharmaceutical and biotechnology companies are
expected to foster growth of western blotting market. According to a news
journal, biotech companies spent USD 40.1 billion in 2015 on R&D
activities, which was a 16% rise from their 2014 investments. Hence, with
rising number of R&D activities, there is an expected rise in the demand
for western blotting tests in the near future.
Access
Research Report of Western Blotting Market@
www.grandviewresearch.com/industry-analysis/western-blotting-market
Further key findings from the study suggest:
· In 2016, consumables segment held the
largest market share and is also expected to exhibit fastest growth over the
forecast period owing to rising diagnostic and research-based activities
requiring western blotting
· Amongst the application segment, biomedical
& biochemical research contributed towards the largest revenue share in
2016 due to increasing government spending in proteomics research
· The disease diagnostics segment is
anticipated to witness highest CAGR over the forecast period due to rising
epidemiology of HIV, Lyme, and other related diseases
· Amongst the end-use segment, such as
academic & research institutes dominated the market in 2016 owing to
growing number of research activities conducted by educational institutions
supported by government funding
· The pharmaceutical and biotechnology
companies are expected to grow at a significant CAGR over the forecast period
due to increasing R&D spending by such companies
· Some of the key players are Bio-Rad
Laboratories, Inc., Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche Ltd.,
GE Healthcare, LI-COR Biosciences, Bio-Techne Corporation, PerkinElmer, Inc.,
and Merck KGaA.
Browse more reports of this category by Grand View
Research at: www.grandviewresearch.com/industry/medical-devices
Grand View Research has segmented the
western blotting market on the basis of product, application, end-use and
region:
Western Blotting Product Outlook (Revenue,
USD Million; 2014 - 2025)
·
Instruments
·
Consumables
Western Blotting Application Outlook (Revenue, USD
Million; 2014 - 2025)
·
Biomedical & Biochemical Research
·
Disease Diagnostics
·
Agriculture
·
Others
Western Blotting End-Use Outlook (Revenue,
USD Million; 2014 - 2025)
·
Academic & Research Institutes
·
Pharmaceutical & Biotechnology
Companies
·
Diagnostic Centers
·
Others
Western Blotting Regional Outlook (Revenue,
USD Million; 2014 - 2025)
·
North America
·
Europe
·
Asia Pacific
·
Latin America
·
MEA
Access Press Release of
Western Blotting Market@ www.grandviewresearch.com/press-release/global-western-blotting-market
About
Grand View Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco.
The company provides syndicated research reports, customized research
reports, and consulting services. To help clients make informed business
decisions, we offer market intelligence studies ensuring relevant and
fact-based research across a range of industries, from technology to chemicals,
materials and healthcare.
No comments:
Post a Comment